Evidence map›Paper›PMID 18628315›Full record

ArticleJournal of medical genetics2008

Clinical and molecular delineation of the 17q21.31 microdeletion syndrome.

D A Koolen, A J Sharp, J A Hurst, H V Firth, S J L Knight, A Goldenberg, P Saugier-Veber, R Pfundt, L E L M Vissers, A Destrée and 38 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of medical genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 217 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

48 authors at 20 institutions in 11 countries.

D A KoolenDepartment of Human Genetics, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
A J Sharp
J A Hurst
H V Firth
S J L Knight
A Goldenberg
P Saugier-Veber
R Pfundt
L E L M Vissers
A Destrée
B Grisart
L Rooms
N Van der Aa
M Field
A Hackett
K Bell
M J M Nowaczyk
G M S Mancini
P J Poddighe
C E Schwartz
E Rossi
M De Gregori
L L Antonacci-Fulton
M D McLellan
J M Garrett
M A Wiechert
T L Miner
S Crosby
R Ciccone
L Willatt
A Rauch
M Zenker
S Aradhya
M A Manning
T M Strom
J Wagenstaller
A C Krepischi-Santos
A M Vianna-Morgante
C Rosenberg
S M Price
H Stewart
C Shaw-Smith
H G Brunner
A O M Wilkie
J A Veltman
O Zuffardi
E E Eichler
B B A de Vries
Washington University in St. Louis · USRadboud University Medical Center · NLAddenbrooke's Hospital · GBUniversidade de São Paulo · BRUniversity of Pavia · ITChurchill Hospital · GBErasmus MC · NLHunter Genetics · AUInserm · FRInstitute of Pathology and Genetics · BEStanford University · USUniversitätsklinikum Erlangen · DEAntwerp University Hospital · BECentre for Human Genetics · GBGreenwood Genetic Center · USHoward Hughes Medical Institute · USIstituti di Ricovero e Cura a Carattere Scientifico · ITJohn Radcliffe Hospital · GBMcMaster University · CAMcMaster University Medical Centre · CA

Funding

SEGMENTAL ANEUSOMY BETWEEN BLOCKS OF DUPLICATED DNAR01HD043569 · NICHD · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2003 to 2007
$2.1M
Howard Hughes Medical InstituteNICHD NIH HHS HD043569NICHD NIH HHS R01 HD043569
6 · The paper itself

Abstract

backgroundThe chromosome 17q21.31 microdeletion syndrome is a novel genomic disorder that has originally been identified using high resolution genome analyses in patients with unexplained mental retardation.

aimWe report the molecular and/or clinical characterisation of 22 individuals with the 17q21.31 microdeletion syndrome.

resultsWe estimate the prevalence of the syndrome to be 1 in 16,000 and show that it is highly underdiagnosed. Extensive clinical examination reveals that developmental delay, hypotonia, facial dysmorphisms including a long face, a tubular or pear-shaped nose and a bulbous nasal tip, and a friendly/amiable behaviour are the most characteristic features. Other clinically important features include epilepsy, heart defects and kidney/urologic anomalies. Using high resolution oligonucleotide arrays we narrow the 17q21.31 critical region to a 424 kb genomic segment (chr17: 41046729-41470954, hg17) encompassing at least six genes, among which is the gene encoding microtubule associated protein tau (MAPT). Mutation screening of MAPT in 122 individuals with a phenotype suggestive of 17q21.31 deletion carriers, but who do not carry the recurrent deletion, failed to identify any disease associated variants. In five deletion carriers we identify a <500 bp rearrangement hotspot at the proximal breakpoint contained within an L2 LINE motif and show that in every case examined the parent originating the deletion carries a common 900 kb 17q21.31 inversion polymorphism, indicating that this inversion is a necessary factor for deletion to occur (p<10(-5)).

conclusionOur data establish the 17q21.31 microdeletion syndrome as a clinically and molecularly well recognisable genomic disorder.

Indexed as

Abnormalities, MultipleChromosome DeletionDevelopmental DisabilitiesAdolescentAdultChildChild, PreschoolChromosome InversionChromosomes, Human, Pair 17FaceFemaleHumansInfantMaleMuscle HypotoniaOligonucleotide Array Sequence AnalysisMAPT protein, humantau Proteins

Identifiers

PMID18628315
PMCPMC3071570
OpenAlexW2162805839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.